CLINICAL_TRIALS
trial_result
· 2013-04-05
Clinical Trial Update: Rebeccamycin Analog in Treating Patients With Advanced Kidney Cancer [Phase 2]
Summary
This update notes the completion of a Phase 2 trial evaluating a rebeccamycin analog in patients with advanced kidney cancer.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Barbara Ann Karmanos Cancer Institute | Conditions: Kidney Cancer | Phase 2 | Status: COMPLETED